A recent active-controlled trial using subcutaneous ketamine injections over four weeks has demonstrated strong efficacy…
Read More
A new large-scale trial conducted by researchers at the University of New South Wales (UNSW)…
A groundbreaking clinical trial published in the New England Journal of Medicine (NEJM) has reignited…
Major depressive disorder (MDD) continues to be a leading cause of disability worldwide, affecting over…
AbstractAJ, a young man plagued for over 11 years by post‑traumatic stress disorder (PTSD), obsessive‑compulsive…
In the clinical study Efficacy of ketamine therapy in the treatment of depression by Mandal,…
In the systematic review and meta-analysis Ketamine as a Novel Treatment for Major Depressive Disorder…
In the landmark study A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients…
In the study Ketamine’s dose-related effects on anxiety symptoms in patients with treatment-refractory anxiety disorders…
In the open-label trial Can exposure-based CBT extend the effects of intravenous ketamine in obsessive-compulsive…
